IP Library Granted Patent US 7,074,571
Granted Patent B2
US 7,074,571 · App. 09/992,600 · Granted Jul 11, 2006

Serine carboxypeptidase hx (SCPhx) and compositions thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,074,571
App. No.
09/992,600
Granted
Jul 11, 2006
Kind
B2
Abstract

The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.

Claims (41)

1. An isolated or purified serine carboxypeptidase (SCPhx) polypeptide:

a) encoded by an isolated polynucleotide comprising an open reading frame of the human cDNA of deposited clone 1000848582 — 181-40-4-0-A11-F (ATCC PTA-2732);

b) comprising amino acids −26 to 267 of SEQ ID NO: 4;

c) comprising amino acids 1 to 267 of SEQ ID NO: 4;

d) consisting of amino acids −26 to 267 of SEQ ID NO: 4; or

e) consisting of amino acids 1 to 267 of SEQ ID NO:4.

2. The isolated or purified SCPhx polypeptide of claim 1 , wherein said polypeptide is encoded by an isolated polynucleotide comprising an open reading frame of the human cDNA of deposited clone 1000848582 — 181-40-4-0-A11-F (ATCC PTA-2732).

3. The isolated or purified SCPhx polypeptide of claim 1 , wherein said polypeptide comprises amino acids −26 to 267 of SEQ ID NO: 4.

4. The isolated or purified SCPhx polypeptide of claim 1 , wherein said polypeptide comprises amino acids 1 to 267 of SEQ ID NO: 4.

5. The isolated or purified SCPhx polypeptide of claim 1 , wherein said polypeptide consists of amino acids −26 to 267 of SEQ ID NO: 4.

6. The isolated or purified SCPhx polypeptide of claim 1 , wherein said polypeptide consists of amino acids 1 to 267 of SEQ ID NO:4.

7. A composition comprising a physiologically acceptable carrier and a serine carboxypeptidase (SCPhx) polypeptide:

a) encoded by an isolated polynucleotide comprising an open reading frame of the human cDNA of deposited clone 1000848582 — 181-40-4-0-11-F (ATCC PTA-2732);

b) comprising amino acids −26 to 267 of SEQ ID NO: 4;

c) comprising amino acids 1 to 267 of SEQ ID NO: 4;

d) consisting of amino acids −26 to 267 of SEQ ID NO: 4; or

e) consisting of amino acids 1 to 267 of SEQ ID NO:4.

8. The composition of claim 7 , wherein said SCPhx polypeptide is encoded by an isolated polynucleotide comprising an open reading frame of the human cDNA of deposited clone 1000848582 — 181-40-4-0-A11-F (ATCC PTA-2732).

9. The composition of claim 7 , wherein said SCPhx polypeptide comprises amino acids −26 to 267 of SEQ ID NO: 4.

10. The composition of claim 7 , wherein said SCPhx polypeptide comprises amino acids 1 to 267 of SEQ ID NO: 4.

11. The composition of claim 7 , wherein said SCPhx polypeptide consists of amino acids −26 to 267 of SEQ ID NO: 4.

12. The composition of claim 7 , wherein said SCPhx polypeptide consists of amino acids 1 to 267 of SEQ ID NO:4.

13. A method of making a serine carboxypeptidase (SCPhx) polypeptide, said method comprising:

a) providing a population of cells comprising a polynucleotide encoding a SCPhx polypeptide operably linked to a promoter, said SCPhx polypeptide:

i) being encoded by an isolated polynucleotide comprising an open reading frame of the human cDNA of deposited clone 1000848582 — 181-40-4-0-A11-F (ATCC PTA-2732);

ii) comprising amino acids −26 to 267 of SEQ ID NO: 4;

iii) comprising amino acids 1 to 267 of SEQ ID NO: 4;

iv) consisting of amino acids −26 to 267 of SEQ ID NO: 4; or

v) consisting of amino acids 1 to 267 of SEQ ID NO:4;

b) culturing said population of cells under conditions conducive to the production of said polypeptide within said cells; and

c) purifying said polypeptide from said population of cells.

14. The method of claim 13 , wherein said polynucleotide is encoded by an isolated polynucleotide comprising an open reading frame of the human cDNA of deposited clone 1000848582 — 181-40-4-0-A11-F (ATCC PTA-2732).

15. The method of claim 13 , wherein said polynucleotide encodes a polypeptide comprising amino acids −26 to 267 of SEQ ID NO: 4.

16. The method of claim 13 , wherein said polynucleotide encodes a polypeptide comprising amino acids 1 to 267 of SEQ ID NO: 4.

17. The method of claim 13 , wherein said polynucleotide encodes a polypeptide consisting of amino acids −26 to 267 of SEQ ID NO: 4.

18. A method of binding a SCPhx polypeptide according to claim 1 to an antibody comprising contacting said antibody with said polypeptide under conditions in which said antibody can specifically bind to said polypeptide.

19. The method of claim 18 , wherein said SCPhx polypeptide is encoded by an isolated polynucleotide comprising an open reading frame of the human cDNA of deposited clone 1000848582 — 181-40-4-0-A11-F (ATCC PTA-2732).

20. The method of claim 18 , wherein said SCPhx polypeptide comprises amino acids −26 to 267 of SEQ ID NO: 4.

21. The method of claim 18 , wherein said SCPhx polypeptide comprises amino acids 1 to 267 of SEQ ID NO: 4.

22. The method of claim 18 , wherein said SCPhx polypeptide consists of amino acids −26 to 267 of SEQ ID NO: 4.

23. The method of claim 18 , wherein said SCPhx polypeptide consists of amino acids 1 to 267 of SEQ ID NO:4.

Assignments (3)
CHANGE OF NAME Recorded Aug 3, 2005
From: GENSET S.A.
To: SERONO GENETICS INSTITUTE S.A.
Reel/Frame 016348/0865 →
CHANGE OF ASSIGEE ADDRESS Recorded Aug 25, 2003
From: GENSET S.A.
To: GENSET S.A.
Reel/Frame 013907/0449 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2002
From: BEJANIN, STEPHANE; TANAKA, HIROAKI
To: GENSET S.A.
Reel/Frame 012861/0142 →